Columbia Asset Management »

Vertex Pharmaceuticals shares owned by Columbia Asset Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals shares owned by Columbia Asset Management from 13F filings

Historical chart of Columbia Asset Management investment in Vertex Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals held by Columbia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals by Columbia Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $218k 537 405.96
2023-12-31 $218k 537 405.96

More positions owned by Columbia Asset Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Erie Indemnity Co Cl A Cl A (ERIE)
Visa Com Cl A (V)
Merck & Co (MRK)
Amazon (AMZN)
Berkshire Hathaway Cl B Cl B New (BRK.B)
Alphabet Inc Class A Cap Stk Cl A (GOOGL)
Vanguard S&P 500 Etf S&p 500 Etf Shs (VOO)
Adobe Systems Incorporated (ADBE)
Johnson & Johnson (JNJ)
Nike Inc Class B CL B (NKE)
Broadcom (AVGO)
Starbucks Corporation (SBUX)
Morgan J P & Co Nasdaq 100 Ex (QQXT)

View all positions for Columbia Asset Management

Top funds holding Vertex Pharmaceuticals

Columbia Asset Management

View all funds holding Vertex Pharmaceuticals